Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells
ISSN号:1671-4083
期刊名称:《中国药理学报:英文版》
分类:Q55[生物学—生物化学] TQ463.54[化学工程—制药化工]
作者机构:[1]Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China, [2]State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
相关基金:Acknowledgements This work was supported by funds from the National Program on Key Basic Research Project of China (No 2012CB910704), the Natural Science Foundation of China for Innovation Research Group (No 81021062), the National Natural Science Foundation of China (No 81102461), and the National S&T Major Projects (2012ZX09301001-007).